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Abstract
Study Objectives: To explore impairments in social functioning in children with narcolepsy compared to healthy children.
Methods: Parents of 53 pediatric patients with narcolepsy type 1 and 64 matched healthy children completed the Social Responsiveness Scale (SRS) and the Child 
Behavior Checklist 6–18 (CBCL 6–18).
Results: Patients scored significantly higher on the total score of the SRS (median 56, interquartile range [IQR] 23.5) compared to controls (median 44.5, IQR 8.5, 
U = 797.0, p < 0.001). Patients also scored higher on the sum of the CBCL 6–18 subscales indicative of social functioning (Withdrawn/Depressed, Social Problems, and 
Thought Problems; median 183, IQR 30.5) compared to controls (median 155, IQR 13, U = 500.0, p < 0.001). A total of 24 patients (45.3%) reported at least mild-to-
moderate difficulties in social functioning compared to seven controls (10.9%, χ2 = 17.165, p < 0.001). Eleven patients (20.8%) and only one control (1.6%) had T scores 
above 75, which points to severely impaired social functioning (χ2 = 11.602, p = 0.001). Within the patient group, girls reported mild-to-moderate difficulties in social 
functioning significantly more often compared to boys on the SRS (77.8% versus 28.6%, χ2 = 17.560, p < 0.001).
Conclusions: Impaired social functioning is common in children with narcolepsy type 1, especially in girls. Questionnaires such as the SRS and the CBCL 6–18 may help 
in early detection of social problems in pediatric narcolepsy. Recognition of these problems could be valuable in the management of young people with narcolepsy.
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Statement of Significance
Hypocretin deficiency causes hypersomnolence and cataplexy as the core symptoms of narcolepsy but has also been suggested to affect 
emotion regulation and social behavior. This study supports previous suspicions that social development is disturbed in children with 
narcolepsy. Childhood is a critical period for the development of social relationships at school, in the community, and in the family. Any 
failure in this area can lead to inferior development of social skills and can have further negative effects on mental health and well-being, 
hence considerably affecting the quality of life in these children. Early detection of these problems, making use of proper questionnaires, 
makes it possible to provide appropriate and personalized care.
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Introduction
Narcolepsy is a chronic neurologic sleep disorder with an estimated 
prevalence of 25–50 per 100 000 [1]. It is caused by a deficiency 
of the hypocretin neuropeptides produced in dorsolateral 
hypothalamic neurons, most likely through an autoimmune 
destruction of hypocretin cells [2, 3]. Narcolepsy is primarily 
characterized by excessive daytime sleepiness and cataplexy. 
However, next to these core symptoms, patients often have other 
complaints including fragmented sleep, obesity, fatigue, as well 
as anxiety and mood disorders [4]. Although narcolepsy has 
traditionally been thought of as a disease of early adulthood, at 
least one third of the cases start before the age of 15 years [5]. The 
diagnosis of narcolepsy in children is challenging, especially at 
young age. For example, cataplexy can be challenging for children 
to describe [6] and can have different features compared to 
adulthood, such as a prominent facial involvement and positive 
motor phenomena such as tongue and perioral movements [7]. 
Moreover, sleepiness in children is often expressed in the form 
of behavioral problems such as distractibility and hyperactivity, 
and can thus be missed easily. As a consequence, the diagnostic 
process in children with suspected narcolepsy is complex and 
these children are at increased risk of their condition being 
unrecognized, misinterpreted, and misdiagnosed.
Psychiatric disorders, in particular mood and anxiety 
disorders, have been shown to be more frequent in adults 
with narcolepsy compared to the general population [8–10]. 
Some pediatric studies highlight an increased representation 
of internalizing and externalizing problems, more depressive 
symptoms, significant levels of attention-deficit hyperactivity 
disorder symptoms, and a decreased quality of life [11–15]. Two 
studies were performed concerning autism spectrum symptoms 
in children with narcolepsy. Huang et al. [16] found that 20% of 
the people with narcolepsy fulfilled the criteria of Asperger’s 
syndrome, compared to 2.7% of the control group. Szakács et al. 
[17] observed that 3 of 37 patients had autistic traits, whereas 1 
of 37 fulfilled the criteria of a pervasive developmental disorder 
not otherwise specified [17]. Recently, Prihodova et  al. [18] 
described four case reports in which childhood narcolepsy was 
accompanied by a diagnosis of an autism spectrum disorder 
(ASD) . Although these studies used semi-structured interviews 
allowing a clinical diagnosis, the drawing of strong conclusions 
was hampered by a relatively small number of participants and 
people with a mixture of narcolepsy type 1 and 2 (the latter 
without hypocretin deficiency). Moreover, it is possible that 
children with narcolepsy experience relevant difficulties in 
social functioning, without fulfilling the formal criteria of an 
ASD. The causes of these psychological and psychiatric problems 
are often attributed to sleepiness or the presence of a chronic 
disorder [19]. This would imply that proper treatment of the core 
symptoms would decrease the incidence of these disorders. 
However, the underlying pathophysiological mechanism of 
narcolepsy, i.e. the hypocretin loss, might also contribute, as 
hypocretin signaling is not restricted to the regulation of sleep/
wake processes but has been suggested to play a role in emotion 
regulation and social behavior as well [20–22]. In addition, 
there is also evidence linking the hypocretin system to several 
primary psychiatric disorders, including mood, anxiety and 
eating disorders, schizophrenia, and addiction [23].
The aim of this study was to investigate social functioning in 
a large sample of children with narcolepsy type 1 versus age- and 
sex-matched healthy controls using the Social Responsiveness 
Scale (SRS) and the Child Behavior Checklist 6–18 (CBCL 6–18).
Methods
Participants
Patients were recruited from April 2014 till April 2016. We provided 
study information to all children with narcolepsy and their 
parents in the outpatient clinics of the Center for Sleep Medicine, 
Kempenhaeghe (Heeze, the Netherlands), Sleep-Wake Center 
SEIN (Heemstede, the Netherlands), Sleep Center of the Medical 
Center Haaglanden (Den Haag, the Netherlands), and the Pediatric 
Sleep Center of the University Hospital Ghent (Ghent, Belgium). 
Patients were included if they fulfilled the criteria of narcolepsy 
type 1, according to the standards of the International Classification 
of Sleep Disorders, Third Edition, Diagnostic and Coding Manual [24]. 
Patient with symptomatic narcolepsy due to brain lesions or 
syndromes such as Niemann–Pick C or Prader–Willi syndrome 
were excluded. Diagnoses were confirmed by review of the medical 
records, including clinical notes, overnight sleep studies, multiple 
sleep latency tests, human leukocyte antigen (HLA) typing, 
and cerebrospinal fluid (CSF) hypocretine-1 levels. All patients 
received standard treatment consisting of behavioral advices and 
modifications, medication, and/or academic guidance.
The children and adolescents in the control group were 
recruited through advertisement in social media and newsletters 
of surrounding schools. We only included patients and controls 
between 7 and 16  years of age. Exclusion criteria for both 
groups were an intellectual disability in (one of) the parents or 
insufficient command of the Dutch language of the parents.
Consent and study procedure
The treating physician informed patients and their parents 
about the study, both orally and in written form. Control 
participants and their parents were informed by the researcher 
in the same manner. After the patient or control and the parents 
agreed to participate, written consent forms were signed. 
We requested informed consent from both the child and the 
parent even though only the parents were asked to fill out the 
questionnaires. Questionnaires were sent to the home address 
and filled-in forms were returned by mail to the researcher. The 
study was approved by the medical ethics committee of the 
Leiden University Medical Center, Leiden, the Netherlands.
Questionnaires
Social Responsiveness Scale
The SRS is a 65-item parent and/or teacher report questionnaire 
designed to assess autistic symptoms as a quantitative trait [25]. 
Five domains are assessed: social awareness, social information 
processing, capacity for reciprocal communication, social 
anxiety/avoidance, and autistic preoccupation and mannerisms. 
Each item is scored on a Likert scale ranging from 1 (not true) 
to 4 (almost always true). Raw scores are converted to T scores, 
adjusted for age and sex. A T score between 61 and 75 is indicative 
of mild-to-moderate impaired social functioning; a score above 
75 is highly suggestive of an ASD. The psychometric properties 
of the SRS have been previously described in reports on studies 
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of cumulatively more than 900 children aged 4–18 years [25–28]. 
The internal consistency is high for both males and females 
(Cronbach’s α .90) and the instrument has shown temporal 
stability (test–retest reliability at 17 months: r = .85 for males and 
.77 for females). The SRS measures impairment on a quantitative 
scale across a wide range of severities—which is consistent with 
recent research indicating that autism is best conceptualized as 
a spectrum condition rather than an all-or-nothing diagnosis 
[29]. This is important as even mild degrees of impairment can 
have significant adverse effects on social functioning [28].
Child Behavior Checklist 6–18
The CBCL 6–18 consists of 113 items and is to be completed by 
a parent. It is a well-established and widely used measure of 
emotional, behavioral, and social problems in children between 
6 and 18 years of age [30]. The items concern the child’s specific 
behaviors, emotions, and emotional problems within the past 
6 months on a scale ranging from “0” (not true) to “2” (very true 
of often true). Raw scores are converted to T scores, adjusted for 
age and sex. Results are expressed in eight different “syndrome 
scales” (Anxious/Depressed,   Withdrawn/Depressed, Somatic 
Complaints,  Social Problems, Thought Problems, Attention 
Problems, Rule-breaking Behavior, Aggressive Behavior) and six 
“Diagnostic Statistical Manual (DSM) oriented scales” (Affective 
Disorder, Anxiety Disorder, Somatic Disorder, Attention Deficit 
Hyperactivity Disorder, Oppositional Defiant Disorder, Conduct 
Disorder). The good reliability and validity of the CBCL 6–18 has 
been replicated for the Dutch translation [31]. Recently, the creator 
of the instrument proposed that the CBCL 6–18 is also useful for 
specific “social impairment” screening [32]. The sum of CBCL 6–18 
scales “Withdrawn/Depressed”, “Social Problems,” and “Thought 
Problems” (further referred to as CBCL-WST) has been found to 
differentiate well between school-age children with ASDs and 
without ASDs [8, 33–35]. Consistent with the developer’s “border-
line clinical” cutoff point of 65 for the individual syndrome scales, 
a score above 195 (the sum of three subscales) has been proposed 
to indicate problems in social functioning [33].
Statistical analysis
Data processing was performed with the Statistical Package 
for the Social Sciences (SPSS), version 24. To test for sample 
distribution, we used histogram analysis and the Shapiro–Wilk 
test. As the majority of data were not normally distributed, we 
used nonparametric tests to determine statistical significance of 
differences, with a significance level set at p = 0.01. Quantitative 
variables were expressed using the median and interquartile 
range (IQR). Chi-square and Mann–Whitney U-tests were used 
for between-group comparisons of categorical and continuous 
variables, respectively. Correlational analyses were performed 
to investigate associations between clinical variables and the 
outcome parameters. Correlations between the total score on 
the SRS and the CBCL-WST subscores were assessed using 
Pearson r-correlation coefficients.
Results
In total, 68 patients and their parents received information 
about the study. Three of them did not respond; six did return 
the consent form but did not return the questionnaire nor 
responded to our attempts to contact them. Five patients and/
or parents changed their minds about participation and one 
questionnaire got lost in the mail. The remaining 53 patients 
(35 boys and 18 girls) had a mean age of 12.1 ± 2.9 years (range 
7–16 years). The healthy control group consisted of 64 age- and 
sex-matched children and adolescents (35 boys and 29 girls) 
with a mean age of 11.2 ± 2.9 (range 7–16 years).
All patients had cataplexy. Polysomnography and multiple 
sleep latency test results were available for all 53 patients, 
conforming the diagnosis of narcolepsy type 1.  HLA typing 
was performed in 28 patients; all were DQB1*0602 positive. CSF 
hypocretin-1 levels were available in 22 patients, all of whom 
showed a level of <110 pg/ml. More than two thirds (69.8%) of 
the patients used one or more medications to suppress the 
narcolepsy symptoms. The majority used stimulants (66%), and 
a relative small number used antidepressants (15.1%) or sodium 
oxybate (13.2%; Table 1).
Children with narcolepsy scored significantly higher on the 
total score of the SRS (median 56, IQR 23.5), compared to the 
healthy control group (median 44.5, IQR 8.5, U = 797.0, p < 0.001; 
Table 2). Moreover, children with narcolepsy scored significant 
higher on all subscales of the SRS (Table 2). The outcomes on 
the CBCL-WST subitems were also significant higher in the 
narcolepsy group (median 183, IQR 30.5) compared to the healthy 
controls (median 155, IQR 13, U = 500.0, p < 0.001). The same held 
for total score on the CBCL 6–18 (see Table 2).
Twenty-four children with narcolepsy (45.3%) had total 
scores of 61 or higher on SRS, which reflects mild-to-moderate 
difficulties in social functioning, compared to 7 of 64 healthy 
controls (10.9%, χ2 = 17.560, p < 0.001; see Table 3). Eleven children 
with narcolepsy (20.9%) and only one healthy control (1.2%) had 
T scores above 75 (χ2  =  11.602, p  =  0.001), which is considered 
severely increased and strongly associated with a clinical 
diagnosis of autistic disorder (Table  3). On the CBCL-WST, 16 
children with narcolepsy (30.2%) had scores of 195 or higher, 
compared to only 1 (1.6%) healthy control (χ2 = 19.130, p = 0.001).
Significant differences were found when comparing 
narcoleptic boys and girls. Girls scored significantly higher 
compared to boys on the SRS (girls: median 66.5, IQR 24.3; 
boys: median 51, IQR 15; U = 166.5, p < 0.005) and on the CBCL-
WST (girls: median 196.5, IQR 32; boys: median 174, IQR 31; 
U = 165, p < 0.005). Fourteen of 18 girls with narcolepsy (77.8%) 
had an SRS score above 61 compared to 10 (28.6%) of the boys 
(χ2  =  17.560, p  =  0.001). Seven girls (38.9%) and 4 boys (11.4%) 
scored above 75 (χ2 = 11.602, p = 0.001). On the CBCL-WST, nine 
Table 1. Demographic variables and medication use
 Patients Controls P
N 53 64
Age, yr 12.1 ± 2.9 11.2 ± 2.9 0.578
Male, N (%) 35 (66.0) 35 (54.7) 0.231
Medication total, N (%) 37 (69.8) —
Stimulants, N (%) 35 (66.0) —
Antidepressants, N (%) 8 (15.1) —
Sodium oxybate, N (%) 7 (13.2) —
Data as mean ± SD. Medication total: number of patients using any 
(combination of) narcolepsy medication; Stimulants: modafinil, 
methylphenidate; antidepressants: tricyclics or selective serotonin reuptake 
inhibitors (SSRIs).
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girls (50%) had scores of 195 or higher, compared to seven boys 
(20.0%; χ2 = 19.130, p = 0.001; see Figure 1).
There was a high correlation between the SRS score and 
the combined CBCL-WST scale (r = .698, p < 0.001). Correlation 
analyses between age, medication use or daytime sleepiness, 
and SRS or CBCL 6–18 scores yielded no significant outcomes, in 
either the whole group or for both sexes separately. Age of onset 
and disease duration were not significantly correlated with any 
of the SRS or CBCL 6–18 scores.
Discussion
In our cohort of children with narcolepsy type 1, relevant social 
impairment affected 45% of the patients. Our study supports 
the trend shown in previous studies in which higher rates of 
disturbed social functioning were found in narcolepsy [16, 17].
Our data show that attention for the social functioning of 
young people with narcolepsy type 1 is meaningful and necessary. 
Childhood and especially adolescence is a critical period in the 
development of relationships with others. Disturbances in social 
development can influence these relationships in a negative 
way but can also play a role in poor academic achievements, 
depressive symptoms, and poor self-esteem.
The current treatment of pediatric narcolepsy is mainly 
focused on symptom reduction of sleepiness, cataplexy, and 
nocturnal sleep, in order to improve quality of life and daytime 
functioning. Treatment mainly consists of pharmacotherapy 
and lifestyle advices and often leaves little room for behavioral 
interventions. All our patients received standard narcolepsy 
treatment in dedicated centers, but nevertheless almost 
half of them significant impaired social functioning. Current 
treatment therefore seems not to fulfill in the needs of these 
young patients. Personalized psychological support might 
contribute to the achievement of treatment goals. Psychological 
treatment has only been investigated very limited with regard 
to narcolepsy, and currently there are no systematic studies on 
the best approach.
Our findings justify attention for the social development of 
patients in the treatment of narcolepsy. We used the SRS in the 
screening of impaired social functioning. The SRS is a dedicated 
and sensitive tool to detect a range of symptoms concerning 
social impairment, including some that are relatively subtle. As 
other studies have found more psychological problems in young 
people with narcolepsy than social impairment alone [11–17, 19, 
36, 37], a more general screening of psychopathology might be 
preferable. To screen for psychological problems, an instrument 
should be quick to administer, require little professional time, 
yield results understood by relevant health and educational 
professionals, and identify children likely to be diagnosed upon 
in depth assessment. The CBCL 6–18 might fit this role, as a 
commonly used worldwide screening tool, which was recently 
proposed as useful for screening of social impairment [32–35]. 
Our data show that instead of using a dedicated screening tool 
such as the SRS, assessing the described (WST) subscales of the 
commonly used CBCL 6–18 can also provide a valid reason to 
consider further psychiatric evaluation.
The nature of the association between narcolepsy and 
psychiatric symptoms in children remains unclear. It has 
been suggested that sleepiness plays an important role in the 
emergence of these symptoms. However, the high presence of 
decreased social functioning in the current cohort, in which 70% 
of patients received medication, implies that other mechanism 
may be involved [19]. There is increasing evidence that the loss 
of hypocretin has a direct impact on psychological well-being 
[38]. A  key feature of hypocretin neurons is their widespread 
projections through the brain, affecting multiple physiological 
functions [39]. Research has shown that hypocretin neurons are 
activated under acute aversive, stress-like conditions and could 
lead to behavior that helps in the coping with these conditions 
[40]. Loss or absence of hypocretin neurons is associated with 
various forms of psychopathology, including depression, eating 
disorders, anxiety, schizophrenia, and addiction problems [23, 
41]. Blouin et  al. [21] reported the highest levels of hypocretin 
in the amygdala during positive emotions, awakening, and 
social interaction in humans. Minimal levels were present in 
situations eliciting withdrawal. It could be hypothesized that 
decreased or absent hypocretin neurotransmission in people 
with narcolepsy type 1 promotes a passive or avoidant response 
pattern, resulting in less adaptive social behavior.
Table  3. Number of children with narcolepsy and controls scoring 
above the cutoffs on the SRS and CBCL-WST
 Narcolepsy Controls χ2 P
SRS ≥ 61, N (%) 24 (45.3) 7 (10.9) 17.560 <0.001
SRS ≥ 76, N (%) 11 (20.8) 1 (1.6) 11.602 0.001
CBCL-WST ≥ 195, 
 N (%)
16 (30.2) 1 (1.6) 19.130 <0.001
Table 2. SRS and CBCL scores in children with narcolepsy and healthy controls
 
Narcolepsy  
(N = 53) (median) IQR
Controls  
(N = 64) (median) IQR U P
SRS total 56 23.5 44.5 8.5 797.00 <0.001
SRS social awareness 53 19 48 10 1255.0 0.015
SRS cognition 54 22 46 10 949.0 <0.001
SRS communication 57 28 45 11 733.0 <0.001
SRS motivation 51 20 46 13.25 1085.5 0.001
SRS preoccupation 54 23 45 7.25 762.5 <0.001
CBCL total 62 16 46.5 11 484.0 <0.001
CBCL Withdrawn/Depressed 60 17 51 5.5 846.0 <0.001
CBCL Social Problems 56 11 51 3 926.0 <0.001
CBCL Thought Problems 66 11.5 51 5.75 429.5 <0.001
CBCL-WST 183 30.5 155 13 500.0 <0.001
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On the other hand, having a chronic illness in general is also 
associated with poorer functioning in the academic, physical, and 
social field [42]. Martinez et al. [43] found stronger impairment 
in social functioning in children with neurological disorders 
than children with cancer or diabetes. In the case of narcolepsy, 
one can presume that the consequences of the narcolepsy 
symptoms lead to fewer opportunities to develop social skills. 
Avis et al. [44] found that sleepiness in children with narcolepsy 
was significantly correlated with social functioning. Stores et al. 
[19] also suggested that excessive daytime sleepiness is the main 
disadvantage for children with narcolepsy. Moreover, children 
with narcolepsy are sometimes estimated by their parents or 
peers as “physically vulnerable,” which may lead to restrictions 
in sports or other social activities. Indeed, Inocente et  al. [45] 
reported fewer relations with friends and lower leisure activities 
in adolescents with narcolepsy compared to healthy controls. 
Also, noticeable and triggerable cataplexy attacks can be a risk 
factor for bullying, which further limits opportunities for social 
functioning or receiving social support. Several studies show 
that children with narcolepsy are at risk of cognitive impairment 
in at least one domain [15]. Cognitive impairment could impair 
academic functioning as well as social understanding, which is 
an aspect of social functioning.
To our surprise, social problems seemed to be more frequent 
in girls with narcolepsy compared to boys. This seems to 
contrast with the general population, as it has been suggested 
that women are more socially skilled, emotionally sensitive 
and expressive compared to men, and have a lower incidence 
of ASDs [46, 47]. We could not find a fitting explanation for this 
finding, so this aspects warrants future research. The same 
holds true for studying the presence of social functioning in 
adult narcolepsy. As mentioned previously, several studies have 
described a higher prevalence of psychiatric comorbidity in 
adult narcolepsy, including eating disorders, anxiety disorders, 
and depressive symptoms [8–10]. Some studies have been 
conducted on personality, and a pattern of social introversion 
and lower levels of socialization has been suggested [48, 49]. 
More specific studies on social functioning in this population 
would be highly relevant.
Although this study used validated questionnaires and 
included a relative large and well-defined cohort of children 
with narcolepsy type 1, several limitations need to be addressed. 
First of all, the study was cross-sectional and observational in 
nature. Therefore, causality cannot be attributed to the findings. 
Second, we relied on parent reports on social functioning of 
the children, which do not provide insight in the perception of 
the children in these matters. Adding reports from the children 
themselves or from other adult observers such as teachers would 
be a suggestion for future work. The fact that the SRS and CBCL 
6–18 are screening tools that do not allow a discrete psychiatric 
diagnosis is not a limitation in our view, as our hypothesis was 
not necessarily that a clinical diagnosis of ASD is more frequent 
in narcolepsy. The found problems in social functioning are 
nonetheless clinically and socially relevant even if not fulfilling 
the formal criteria of an ASD.
In conclusion, the current data highlight that impaired social 
functioning is strikingly prevalent in children with narcolepsy. 
These impairments are hypothesized to impact on a broader 
sense of psychological well-being. We therefore recommend a 
more structural assessment of psychological health and—when 
required—intensive psychosocial support in the treatment of 
pediatric narcolepsy, preferably integrated in a multidisciplinary 
setting. Instead of using a dedicated screening tool such as the 
SRS, application of the more commonly used CBCL 6–18 can 
provide a valid reason to consider further psychiatric evaluation. 
Recognition of impairments in social functioning could be 
valuable in the management of these patients. However, more 
studies are needed to investigate underlying mechanisms and 
specific treatment strategies in this population.
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